Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Constitutive androstane receptor (CAR) functions as a tumor suppressor via regulating stemness in liver cancer ; volume:14 ; number:1 ; day:28 ; month:12 ; year:2024 ; pages:1-9 ; date:12.2024
Scientific reports ; 14, Heft 1 (28.12.2024), 1-9, 12.2024
- Klassifikation
-
Ingenieurwissenschaften und Maschinenbau
- Urheber
-
Bae, Sarah Da Won
Nguyen, Romario
Yuen, Lawrence
Lam, Vincent
George, Jacob
Qiao, Liang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-81571-z
- URN
-
urn:nbn:de:101:1-2503062113173.917855473159
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bae, Sarah Da Won
- Nguyen, Romario
- Yuen, Lawrence
- Lam, Vincent
- George, Jacob
- Qiao, Liang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Signaling control of the constitutive androstane receptor (CAR)
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway
TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling
Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway
CAR-T overdrive: harnessing inosine for metabolic rewiring and stemness induction
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs
FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness
Granulocytic Myeloid‐Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
The role of LINC01419 in regulating the cell stemness in lung adenocarcinoma through recruiting EZH2 and regulating FBP1 expression
Sensing stemness
Signaling control of the constitutive androstane receptor (CAR)
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway
TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling
Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway
CAR-T overdrive: harnessing inosine for metabolic rewiring and stemness induction
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs
FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness
Granulocytic Myeloid‐Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
The role of LINC01419 in regulating the cell stemness in lung adenocarcinoma through recruiting EZH2 and regulating FBP1 expression
Sensing stemness
Signaling control of the constitutive androstane receptor (CAR)
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway
TRAF7-targeted HOXA5 acts as a tumor suppressor in prostate cancer progression and stemness via transcriptionally activating SPRY2 and regulating MEK/ERK signaling
Fascin induces melanoma tumorigenesis and stemness through regulating the Hippo pathway
CAR-T overdrive: harnessing inosine for metabolic rewiring and stemness induction
P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs
FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness
Granulocytic Myeloid‐Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
The role of LINC01419 in regulating the cell stemness in lung adenocarcinoma through recruiting EZH2 and regulating FBP1 expression